Ken Griffin’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Ken Griffin’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-39,512	Closed	-$518K	–	13960
2022 Q2	$518K	Buy	+39,512	New	+$233K	﹤0.01%	8569

Other funds holding MKUL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ken Griffin's MKUL Position: Q3 2022 in Review

Ken Griffin sold out of Molekule Group, Inc. Common Stock (MKUL) in Q3 2022, closing a stake of 39,512 shares — an estimated $518K sold.

Ken Griffin first reported a position in MKUL in Q2 2022 and held it in 1 quarter. The position peaked at $518K in Q2 2022. 17 funds tracked by Wall St. Rank hold MKUL as of Q3 2022.

Ken Griffin reported no remaining Molekule Group, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Ken Griffin sold 39,512 Molekule Group, Inc. Common Stock shares in Q3 2022, an estimated $518K.
Ken Griffin first reported a position in Molekule Group, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Ken Griffin's Molekule Group, Inc. Common Stock position peaked at $518K in Q2 2022.
17 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.